Loading…
Sunrest Lifescience (SUNREST)₹35.70+0.56%Pharmaceuticals
Sunrest Lifescience is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 7.4 against a peer median of 17.7, and ROCE of 28.5% against a peer median of 7.8%. By market cap it is #8 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shelter Pharma | 76 | 8.3 | 20.4 | 15.1 | 0.01 | 0.8 | 73 | 9 | 49.8 | 22.2 | vs SUNREST |
| Source Natural Foods & Herbal Supplements | 75 | 22.0 | — | — | — | 0.0 | 71 | 3 | 76.3 | 7.8 | vs SUNREST |
| Vineet Laboratories | 73 | — | −28.0 | −89.5 | 2.99 | 0.0 | 75 | −20 | −13.5 | — | vs SUNREST |
| Sunil Healthcare | 72 | 20.0 | 6.5 | 6.0 | 0.80 | 0.0 | 87 | 4 | −16.2 | −50.0 | vs SUNREST |
| Sunil Healthcare | 72 | 20.3 | 6.5 | 6.1 | 0.85 | 0.0 | 87 | 4 | −16.1 | −48.9 | vs SUNREST |
| Zenith Drugs | 68 | 17.1 | 9.1 | 5.8 | 0.73 | 0.0 | 170 | 4 | 40.8 | 99.0 | vs SUNREST |
| Onyx Biotec | 62 | — | 1.1 | −0.4 | 0.27 | 0.0 | 69 | −0 | 9.8 | −64.6 | vs SUNREST |
| Sunrest Lifescience | 61 | 7.4 | 28.5 | 22.4 | 0.86 | 0.0 | 71 | 8 | — | — | — |
| Phaarmasia | 54 | 3.1 | 15.9 | 12.9 | 0.05 | 0.0 | 47 | 18 | 42.3 | — | vs SUNREST |
| Biofil Chemicals & Pharmaceuticals | 50 | 18.3 | 15.8 | 13.8 | 0.14 | 0.0 | 28 | 3 | −9.2 | 5.3 | vs SUNREST |
| Parmax Pharma | 49 | — | −82.9 | — | — | 0.0 | 12 | −4 | −31.5 | — | vs SUNREST |
| Peer median | 68 | 17.7 | 7.8 | 6.1 | 0.73 | 0.0 | 71 | 4 | 0.3 | 5.3 |
Listed companies closest to Sunrest Lifescience in Pharmaceuticals include Shelter Pharma, Source Natural Foods & Herbal Supplements, Vineet Laboratories, Sunil Healthcare, Sunil Healthcare, Zenith Drugs, Onyx Biotec, Phaarmasia.
Shelter Pharma, with a market cap of ₹75.60 Cr.
Sunrest Lifescience trades at a P/E of 7.4; the median of its peer set is 17.7. A P/E above or below the median is a description, not a judgement on value.
Sunrest Lifescience's return on capital employed is 28.5%, above the peer median of 7.8%.